A 1017: Provides for education and outreach for drug-induced movement disorders by the department of health through the health care and wellness education and outreach program.

  
  STATE OF NEW YORK ________________________________________________________________________ 1017 2025-2026 Regular Sessions  IN ASSEMBLY (Prefiled) January 8, 2025 ___________ Introduced by M. of A. PAULIN -- read once and referred to the Committee on Health AN ACT to amend the public health law, in relation to authorizing the health care and wellness education and outreach program to develop and disseminate information regarding drug-induced movement disorders The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Paragraph (h) of subdivision 1 of section 207 of the public 2 health law, as added by a chapter of the laws of 2024 amending the 3 public health law relating to establishing a drug-induced movement 4 disorder screening education program, as proposed in legislative bills 5 numbers S. 8965-A and A. 6799-B, is amended to read as follows: 6 (h) [The department shall develop and conduct a program concerning 7 drug-induced] Drug-induced movement disorders[. Such program shall 8 include but not be limited to, (i) educational information on], includ- 9 ing the importance of screening for and identifying symptoms of drug-in- 10 duced movement disorders[; and (ii) the development and dissemination of 11 educational materials for healthcare providers regarding], treatment for 12 drug-induced movement disorders, [including for services provided via 13 telehealth. Such] and information on methods by which the stigma expe- 14 rienced by people living with drug-induced movement disorders related to 15 the treatment of mental health conditions may be reduced or eliminated. 16 Any such educational materials disseminated to healthcare providers 17 shall be developed [and] in consultation with the commissioner of the 18 office of mental health, disseminated by the department in coordination 19 with relevant healthcare provider groups, and shall include best prac- 20 tices for the treatment and screening of movement disorders informed by 21 the American Psychiatric Association and other professional society 22 practice guidelines. [Such program shall also include education and 23 outreach on the elimination of stigma for people living with drug-in- EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD02693-01-5 
 A. 1017 2 1 duced movement disorders related to the treatment of mental health 2 conditions.] 3 § 2. This act shall take effect on the same date and in the same 4 manner as a chapter of the laws of 2024 amending the public health law 5 relating to establishing a drug-induced movement disorder screening 6 education program, as proposed in legislative bills numbers S. 8965-A 7 and A. 6799-B, takes effect.